Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,697
Closed -$13.4K 275
2023
Q1
$13.4K Buy
2,697
+109
+4% +$690 ﹤0.01% 253
2022
Q4
$64K Sell
2,588
-108
-4% -$530 0.01% 190
2022
Q3
$28K Buy
2,696
+65
+2% +$907 ﹤0.01% 213
2022
Q2
$37K Buy
2,631
+43
+2% +$685 ﹤0.01% 214
2022
Q1
$44K Hold
2,588
﹤0.01% 210
2021
Q4
$64K Hold
2,588
0.01% 190
2021
Q3
$96K Hold
2,588
0.01% 174
2021
Q2
$103K Hold
2,588
0.01% 171
2021
Q1
$77K Sell
2,588
-29
-1% -$812 0.01% 157
2020
Q4
$74K Sell
2,617
-125
-5% -$2.51K 0.01% 159
2020
Q3
$40K Buy
+2,742
New +$45.4K 0.01% 140

Other funds holding VSTM

McAdam LLC's VSTM Position: Q2 2023 in Review

McAdam LLC sold out of Verastem (VSTM) in Q2 2023, closing a stake of 2,697 shares — an estimated $13.4K sold.

McAdam LLC first reported a position in VSTM in Q3 2020 and held it in 11 quarters. The position peaked at $103K in Q2 2021. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

  • McAdam LLC reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
  • McAdam LLC sold 2,697 Verastem shares in Q2 2023, an estimated $13.4K.
  • McAdam LLC first reported a position in Verastem in Q3 2020 and held it in 11 quarters.
  • McAdam LLC's Verastem position peaked at $103K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on McAdam LLC's 13F filing for Q2 2023, filed 2 Aug 2023.